Error loading player: No playable sources found
2095
Metabolism, Obesity, Microbiome, Diet, and Nutrition in GI Cancer
Date
May 18, 2024
Related Products
Gut Microbiome — Ally or Foe for Immune Checkpoint Inhibitors
SOCIETY: AGA This session will explore the complex dynamics between the gut microbiome and immune checkpoint inhibitors, addressing whether specific microbes/metabolites enhance therapeutic outcomes acting as allies or present challenges as potential foes, impacting treatment efficacy and associate…
Gut Microbiota as the Orchestrator of Metabolic Disorders
SOCIETY: AGA The session will provide novel insights into the complex interactions between dietary choices, microbial dynamics, and metabolic health…
Microbiome Modulation Across the Lifespan to Treat Chronic Diseases
SOCIETY: AGA In this session, presenters will provide insights into pioneering nutrition interventions and microbiome modulation strategies from studies that span both pediatric and adult patients…
AGA Diet Management in GI Cancers
The impact of diets on GI cancers has been well documented, however just recently we are understanding how diet impacts tumorigenesis…